| 1 |
Cruz N, Herculano-carvalho M, Roque D, Faria CC, Cascão R, Ferreira HA, Reis CP, Matela N. Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma. Pharmaceutics 2023;15:928. [DOI: 10.3390/pharmaceutics15030928] [Reference Citation Analysis]
|
| 2 |
Franson A, McClellan BL, Varela ML, Comba A, Syed MF, Banerjee K, Zhu Z, Gonzalez N, Candolfi M, Lowenstein P, Castro MG. Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment. Front Med (Lausanne) 2022;9:966458. [PMID: 36186781 DOI: 10.3389/fmed.2022.966458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Cheng K, Zhang H, Guo Q, Zhai P, Zhou Y, Yang W, Wang Y, Lu Y, Shen Z, Wu H. Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study. Front Immunol 2022;13:975695. [DOI: 10.3389/fimmu.2022.975695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Hao M, Zhang L, Chen P. Membrane Internalization Mechanisms and Design Strategies of Arginine-Rich Cell-Penetrating Peptides. Int J Mol Sci 2022;23:9038. [PMID: 36012300 DOI: 10.3390/ijms23169038] [Reference Citation Analysis]
|
| 5 |
Cruz JVR, Batista C, Afonso BDH, Alexandre-moreira MS, Dubois LG, Pontes B, Moura Neto V, Mendes FDA. Obstacles to Glioblastoma Treatment Two Decades after Temozolomide. Cancers 2022;14:3203. [DOI: 10.3390/cancers14133203] [Reference Citation Analysis]
|
| 6 |
Jain S, Chalif EJ, Aghi MK. Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma. Front Oncol 2021;11:812916. [PMID: 35096619 DOI: 10.3389/fonc.2021.812916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 7 |
Soldozy S, Mulligan KM, Zheng DX, Levoska MA, Cullison CR, Elarjani T, Eichberg DG, Ampie LE, Shah AH, Yağmurlu K, Shaffrey ME, Scott JF, Komotar RJ. Oncolytic Virotherapy for Melanoma Brain Metastases, a Potential New Treatment Paradigm? Brain Sci 2021;11:1260. [PMID: 34679325 DOI: 10.3390/brainsci11101260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
